RTTNews | Jan 13, 2021 09:55AM EST

09:54 Wednesday, January 13, 2021 (RTTNews.com) - Acorda Therapeutics, Inc. (ACOR) shares are rising on Wednesday morning trade as the company announced an agreement to sell INBRIJA manufacturing operations in Chelsea, Massachusetts to Catalent for $80 million in cash.

Currently, the shares are at $6.37, up 50.20 percent from the previous close of $4.24 on a volume of 13,012,552. For the 52-week period, the shares have traded in range of $2.52 to $15.30 on average volume of 840,684. The shares have been bullish since December first week.

Read the original article on RTTNews ( https://www.rttnews.com/3160263/stock-alert-acorda-therapeutics-gains-50-on-plan-to-sell-inbrija.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved